Lazertinib,Amivantamab,Carboplatin,Pemetrexed,osimertinib
Yuhan Corp,Janssen,Genmab,AstraZeneca
['sclc', 'chrysalis-2', 'amivantamab', 'nsclc', 'biomarker', 'lazertinib', 'osimertinib']
dr. at #asco23 discusses biomarkers for amivantamab plus lazertinib for #egfr nsclc from chrysalis-2, cohort d (post osimertinib). 108 pts, 10m f/u, most pts still on therapy. 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown, Co-Host Official @IASLC Podcast, #ITYSL, #HereWeGo